| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 143, 1699-1712, Copyright © 1993 by American Society for Investigative Pathology
REGULAR ARTICLES |
J Brett, AM Schmidt, SD Yan, YS Zou, E Weidman, D Pinsky, R Nowygrod, M Neeper, C Przysiecki and A Shaw
Department of Physiology and Cellular Biophysics and Surgery, Columbia University, College of Physicians and Surgeons, New York, New York 10032.
Advanced glycation end products (AGEs), the final products of nonenzymatic glycation and oxidation of proteins, are found in the plasma and accumulate in the tissues during aging and at an accelerated rate in diabetes. A novel integral membrane protein, termed receptor for AGE (RAGE), forms a central part of the cell surface binding site for AGEs. Using monospecific, polyclonal antibody raised to human recombinant and bovine RAGE, immunostaining of bovine tissues showed RAGE in the vasculature, endothelium, and smooth muscle cells and in mononuclear cells in the tissues. Consistent with these data, RAGE antigen and mRNA were identified in cultured bovine endothelium, vascular smooth muscle, and monocyte-derived macrophages. RAGE antigen was also visualized in bovine cardiac myocytes as well as in cultures of neonatal rat cardiac myocytes and in neural tissue where motor neurons, peripheral nerves, and a population of cortical neurons were positive. In situ hybridization confirmed the presence of RAGE mRNA in the tissues, and studies with rat PC12 pheochromocytes indicated that they provide a neuronal-related cell culture model for examining RAGE expression. Pathological studies of human atherosclerotic plaques showed infiltration of RAGE-expressing cells in the expanded intima. These results indicate that RAGE is present in multiple tissues and suggest the potential relevance of AGE-RAGE interactions for modulating properties of the vasculature as well as neural and cardiac function, prominent areas of involvement in diabetes and in the normal aging process.
This article has been cited by other articles:
![]() |
M. J D Griffiths and D. F McAuley RAGE: a biomarker for acute lung injury Thorax, December 1, 2008; 63(12): 1034 - 1036. [Full Text] [PDF] |
||||
![]() |
Y. Tekabe, Q. Li, R. Rosario, M. Sedlar, S. Majewski, B. I. Hudson, A. J. Einstein, A. M. Schmidt, and L. L. Johnson Development of Receptor for Advanced Glycation End Products-Directed Imaging of Atherosclerotic Plaque in a Murine Model of Spontaneous Atherosclerosis Circ Cardiovasc Imaging, November 1, 2008; 1(3): 212 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Raucci, S. Cugusi, A. Antonelli, S. M. Barabino, L. Monti, A. Bierhaus, K. Reiss, P. Saftig, and M. E. Bianchi A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10) FASEB J, October 1, 2008; 22(10): 3716 - 3727. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Queisser, F. M. Kouri, M. Konigshoff, M. Wygrecka, U. Schubert, O. Eickelberg, and K. T. Preissner Loss of RAGE in Pulmonary Fibrosis: Molecular Relations to Functional Changes in Pulmonary Cell Types Am. J. Respir. Cell Mol. Biol., September 1, 2008; 39(3): 337 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z Sternberg, B Weinstock-Guttman, D Hojnacki, P Zamboni, R Zivadinov, K Chadha, A Lieberman, L Kazim, A Drake, P Rocco, et al. Soluble receptor for advanced glycation end products in multiple sclerosis: A potential marker of disease severity Multiple Sclerosis, July 1, 2008; 14(6): 759 - 763. [Abstract] [PDF] |
||||
![]() |
C. Poulopoulou, P. Davaki, P. Sgouropoulos, E. Tsaltas, C. Nikolaou, F. Orfanioutou, and D. Vassilopoulos REDUCED RAGE mRNA IN MONONUCLEAR BLOOD CELLS OF PATIENTS WITH PROBABLE ALZHEIMER DISEASE Neurology, April 22, 2008; 70(17): 1571 - 1573. [Full Text] [PDF] |
||||
![]() |
C. Toth, L. L. Rong, C. Yang, J. Martinez, F. Song, N. Ramji, V. Brussee, W. Liu, J. Durand, M. D. Nguyen, et al. Receptor for Advanced Glycation End Products (RAGEs) and Experimental Diabetic Neuropathy Diabetes, April 1, 2008; 57(4): 1002 - 1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Englert, L. E. Hanford, N. Kaminski, J. M. Tobolewski, R. J. Tan, C. L. Fattman, L. Ramsgaard, T. J. Richards, I. Loutaev, P. P. Nawroth, et al. A Role for the Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis Am. J. Pathol., March 1, 2008; 172(3): 583 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pichiule, J. C. Chavez, A. M. Schmidt, and S. J. Vannucci Hypoxia-inducible Factor-1 Mediates Neuronal Expression of the Receptor for Advanced Glycation End Products following Hypoxia/Ischemia J. Biol. Chem., December 14, 2007; 282(50): 36330 - 36340. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. He, H. Kubo, K. Ishizawa, A. E. Hegab, Y. Yamamoto, H. Yamamoto, and M. Yamaya The role of the receptor for advanced glycation end-products in lung fibrosis Am J Physiol Lung Cell Mol Physiol, December 1, 2007; 293(6): L1427 - L1436. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Leclerc, G. Fritz, M. Weibel, C. W. Heizmann, and A. Galichet S100B and S100A6 Differentially Modulate Cell Survival by Interacting with Distinct RAGE (Receptor for Advanced Glycation End Products) Immunoglobulin Domains J. Biol. Chem., October 26, 2007; 282(43): 31317 - 31331. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Taniguchi, K. Yoshida, T. Ito, M. Tsuda, Y. Mishima, T. Furumatsu, L. Ronfani, K. Abeyama, K.-i. Kawahara, S. Komiya, et al. Stage-Specific Secretion of HMGB1 in Cartilage Regulates Endochondral Ossification Mol. Cell. Biol., August 15, 2007; 27(16): 5650 - 5663. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ding, A. Kantarci, J. A. Badwey, H. Hasturk, A. Malabanan, and T. E. Van Dyke Phosphorylation of Pleckstrin Increases Proinflammatory Cytokine Secretion by Mononuclear Phagocytes in Diabetes Mellitus J. Immunol., July 1, 2007; 179(1): 647 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Ellerman, C. K. Brown, M. de Vera, H. J. Zeh, T. Billiar, A. Rubartelli, and M. T. Lotze Masquerader: High Mobility Group Box-1 and Cancer Clin. Cancer Res., May 15, 2007; 13(10): 2836 - 2848. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Figarola, N. Shanmugam, R. Natarajan, and S. Rahbar Anti-Inflammatory Effects of the Advanced Glycation End Product Inhibitor LR-90 in Human Monocytes Diabetes, March 1, 2007; 56(3): 647 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nakano, K. Fukuhara-Takaki, T. Jono, K. Nakajou, N. Eto, S. Horiuchi, M. Takeya, and R. Nagai Association of Advanced Glycation End Products with A549 Cells, a Human Pulmonary Epithelial Cell Line, Is Mediated by a Receptor Distinct from the Scavenger Receptor Family and RAGE. J. Biochem., May 1, 2006; 139(5): 821 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Uchida, M. Shirasawa, L. B. Ware, K. Kojima, Y. Hata, K. Makita, G. Mednick, Z. A. Matthay, and M. A. Matthay Receptor for Advanced Glycation End-Products Is a Marker of Type I Cell Injury in Acute Lung Injury Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 1008 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Bohlender, S. Franke, G. Stein, and G. Wolf Advanced glycation end products and the kidney Am J Physiol Renal Physiol, October 1, 2005; 289(4): F645 - F659. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pamplona, E. Dalfo, V. Ayala, M. J. Bellmunt, J. Prat, I. Ferrer, and M. Portero-Otin Proteins in Human Brain Cortex Are Modified by Oxidation, Glycoxidation, and Lipoxidation: EFFECTS OF ALZHEIMER DISEASE AND IDENTIFICATION OF LIPOXIDATION TARGETS J. Biol. Chem., June 3, 2005; 280(22): 21522 - 21530. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bartling, H.-S. Hofmann, B. Weigle, R.-E. Silber, and A. Simm Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma Carcinogenesis, February 1, 2005; 26(2): 293 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Dahlin, E. M. Mager, L. Allen, Z. Tigue, L. Goodglick, M. Wadehra, and L. Dobbs Identification of Genes Differentially Expressed in Rat Alveolar Type I Cells Am. J. Respir. Cell Mol. Biol., September 1, 2004; 31(3): 309 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Basta, A. M. Schmidt, and R. De Caterina Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes Cardiovasc Res, September 1, 2004; 63(4): 582 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lu, J. C. He, W. Cai, H. Liu, L. Zhu, and H. Vlassara Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells PNAS, August 10, 2004; 101(32): 11767 - 11772. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. F. Hou, H. Ren, W. F. Owen Jr, Z. J. Guo, P. Y. Chen, A. M. Schmidt, T. Miyata, and X. Zhang Enhanced Expression of Receptor for Advanced Glycation End Products in Chronic Kidney Disease J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1889 - 1896. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sorci, F. Riuzzi, C. Arcuri, I. Giambanco, and R. Donato Amphoterin Stimulates Myogenesis and Counteracts the Antimyogenic Factors Basic Fibroblast Growth Factor and S100B via RAGE Binding Mol. Cell. Biol., June 1, 2004; 24(11): 4880 - 4894. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Valencia, M. Mone, J. Zhang, M. Weetall, F. P. Buxton, and T. E. Hughes Divergent Pathways of Gene Expression Are Activated by the RAGE Ligands S100b and AGE-BSA Diabetes, March 1, 2004; 53(3): 743 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C.B. Tan, W.-S. Chow, S. Tam, R. Bucala, and J. Betteridge Association Between Acute-Phase Reactants and Advanced Glycation End Products in Type 2 Diabetes Diabetes Care, January 1, 2004; 27(1): 223 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kaminski, J. A. Belperio, P. B. Bitterman, L. Chen, S. W. Chensue, A. M.K. Choi, S. Dacic, J. H. Dauber, R. M. du Bois, J. J. Enghild, et al. Idiopathic Pulmonary Fibrosis Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): S1 - 105. [Full Text] [PDF] |
||||
![]() |
Z. Zhou, K. Wang, M. S. Penn, S. P. Marso, M. A. Lauer, F. Forudi, X. Zhou, W. Qu, Y. Lu, D. M. Stern, et al. Receptor for AGE (RAGE) Mediates Neointimal Formation in Response to Arterial Injury Circulation, May 6, 2003; 107(17): 2238 - 2243. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wendt, N. Tanji, J. Guo, B. I. Hudson, A. Bierhaus, R. Ramasamy, B. Arnold, P. P. Nawroth, S. F. Yan, V. D'Agati, et al. Glucose, Glycation, and RAGE: Implications for Amplification of Cellular Dysfunction in Diabetic Nephropathy J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1383 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fiuza, M. Bustin, S. Talwar, M. Tropea, E. Gerstenberger, J. H. Shelhamer, and A. F. Suffredini Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells Blood, April 1, 2003; 101(7): 2652 - 2660. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pettersson-Fernholm, C. Forsblom, B. I. Hudson, M. Perola, P. J. Grant, and P.-H. Groop The Functional -374 T/A RAGE Gene Polymorphism Is Associated With Proteinuria and Cardiovascular Disease in Type 1 Diabetic Patients Diabetes, March 1, 2003; 52(3): 891 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Morcos, A. A.R. Sayed, A. Bierhaus, B. Yard, R. Waldherr, W. Merz, I. Kloeting, E. Schleicher, S. Mentz, R. F. Abd el Baki, et al. Activation of Tubular Epithelial Cells in Diabetic Nephropathy Diabetes, December 1, 2002; 51(12): 3532 - 3544. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Huttunen, C. Fages, J. Kuja-Panula, A. J. Ridley, and H. Rauvala Receptor for Advanced Glycation End Products-binding COOH-terminal Motif of Amphoterin Inhibits Invasive Migration and Metastasis Cancer Res., August 15, 2002; 62(16): 4805 - 4811. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. F. Hou, J. P. Jiang, J. Q. Guo, G. B. Wang, X. Zhang, D. M. Stern, A. M. Schmidt, and W. F. Owen Jr. Receptor for Advanced Glycation End Products on Human Synovial Fibroblasts: Role in the Pathogenesis of Dialysis-Related Amyloidosis J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1296 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hattori, M. Suzuki, S. Hattori, and K. Kasai Vascular Smooth Muscle Cell Activation by Glycated Albumin (Amadori Adducts) Hypertension, January 1, 2002; 39(1): 22 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Egleton, S. A. Mitchell, J. D. Huber, M. M. Palian, R. Polt, and T. P. Davis Improved Blood-Brain Barrier Penetration and Enhanced Analgesia of an Opioid Peptide by Glycosylation J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 967 - 972. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bierhaus, S. Schiekofer, M. Schwaninger, M. Andrassy, P. M. Humpert, J. Chen, M. Hong, T. Luther, T. Henle, I. Kloting, et al. Diabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-{kappa}B Diabetes, December 1, 2001; 50(12): 2792 - 2808. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Sousa, S. Du Yan, R. Fernandes, A. Guimaraes, D. Stern, and M. J. Saraiva Familial Amyloid Polyneuropathy: Receptor for Advanced Glycation End Products-Dependent Triggering of Neuronal Inflammatory and Apoptotic Pathways J. Neurosci., October 1, 2001; 21(19): 7576 - 7586. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Kent, V. M. Soukup, and R. H. Fabian Heterogeneity Affecting Outcome From Acute Stroke Therapy: Making Reperfusion Worse Stroke, October 1, 2001; 32(10): 2318 - 2327. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Yeh, L. Sturgis, J. Haidacher, X.-N. Zhang, S. J. Sherwood, R. J. Bjercke, O. Juhasz, M. T. Crow, R. G. Tilton, and L. Denner Requirement for p38 and p44/p42 Mitogen-Activated Protein Kinases in RAGE-Mediated Nuclear Factor-{kappa}B Transcriptional Activation and Cytokine Secretion Diabetes, June 1, 2001; 50(6): 1495 - 1504. [Abstract] [Full Text] |
||||
![]() |
B. I. Hudson, M. H. Stickland, T. S. Futers, and P. J. Grant Effects of Novel Polymorphisms in the RAGE Gene on Transcriptional Regulation and Their Association With Diabetic Retinopathy Diabetes, June 1, 2001; 50(6): 1505 - 1511. [Abstract] [Full Text] |
||||
![]() |
K. Ozawa, Y. Tsukamoto, O. Hori, Y. Kitao, H. Yanagi, D. M. Stern, and S. Ogawa Regulation of Tumor Angiogenesis by Oxygen-regulated Protein 150, an Inducible Endoplasmic Reticulum Chaperone Cancer Res., May 1, 2001; 61(10): 4206 - 4213. [Abstract] [Full Text] |
||||
![]() |
A. Nitenberg, S. Ledoux, P. Valensi, R. Sachs, J.-R. Attali, and I. Antony Impairment of Coronary Microvascular Dilation in Response to Cold Pressor-Induced Sympathetic Stimulation in Type 2 Diabetic Patients With Abnormal Stress Thallium Imaging Diabetes, May 1, 2001; 50(5): 1180 - 1185. [Abstract] [Full Text] |
||||
![]() |
B. Degryse, T. Bonaldi, P. Scaffidi, S. Muller, M. Resnati, F. Sanvito, G. Arrigoni, and M. E. Bianchi The High Mobility Group (HMG) Boxes of the Nuclear Protein HMG1 Induce Chemotaxis and Cytoskeleton Reorganization in Rat Smooth Muscle Cells J. Cell Biol., March 19, 2001; 152(6): 1197 - 1206. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Weindruch, K. P. Keenan, J. M. Carney, G. Fernandes, R. J. Feuers, R. A. Floyd, J. B. Halter, J. J. Ramsey, A. Richardson, G. S. Roth, et al. Caloric Restriction Mimetics: Metabolic Interventions J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2001; 56(90001): 20 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Yan, A. Roher, A. M. Schmidt, and D. M. Stern Cellular Cofactors for Amyloid {beta}-Peptide-Induced Cell Stress : Moving from Cell Culture to in Vivo Am. J. Pathol., November 1, 1999; 155(5): 1403 - 1411. [Full Text] [PDF] |
||||
![]() |
T. Kislinger, C. Fu, B. Huber, W. Qu, A. Taguchi, S. Du Yan, M. Hofmann, S. F. Yan, M. Pischetsrieder, D. Stern, et al. Nepsilon -(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression J. Biol. Chem., October 29, 1999; 274(44): 31740 - 31749. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Renard, O. Chappey, M. P. Wautier, M. Nagashima, J. Morser, J. M. Scherrmann, and J. L. Wautier The Human and Rat Recombinant Receptors for Advanced Glycation End Products Have a High Degree of Homology but Different Pharmacokinetic Properties in Rats J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1458 - 1466. [Abstract] [Full Text] |
||||
![]() |
H. J. Huttunen, C. Fages, and H. Rauvala Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-kappa B Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling Pathways J. Biol. Chem., July 9, 1999; 274(28): 19919 - 19924. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. SUZUKI, T. MIYATA, N. SAOTOME, K. HORIE, R. INAGI, Y. YASUDA, K. UCHIDA, Y. IZUHARA, M. YAGAME, H. SAKAI, et al. Immunohistochemical Evidence for an Increased Oxidative Stress and Carbonyl Modification of Proteins in Diabetic Glomerular Lesions J. Am. Soc. Nephrol., April 1, 1999; 10(4): 822 - 832. [Abstract] [Full Text] |
||||
![]() |
A. M. Schmidt, S. D. Yan, J.-L. Wautier, and D. Stern Activation of Receptor for Advanced Glycation End Products : A Mechanism for Chronic Vascular Dysfunction in Diabetic Vasculopathy and Atherosclerosis Circ. Res., March 19, 1999; 84(5): 489 - 497. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, S. Ren, D. Sun, and G. X. Shen Influence of Glycation on LDL-Induced Generation of Fibrinolytic Regulators in Vascular Endothelial Cells Arterioscler. Thromb. Vasc. Biol., July 1, 1998; 18(7): 1140 - 1148. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Reckelhoff, V. Kanji, L. C. Racusen, A. M. Schmidt, S. Du Yan, J. Morrow, L. J. Roberts II, and A. K. Salahudeen Vitamin E ameliorates enhanced renal lipid peroxidation and accumulation of F2-isoprostanes in aging kidneys Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R767 - R774. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bierhaus, T. Illmer, M. Kasper, T. Luther, P. Quehenberger, H. Tritschler, P. Wahl, R. Ziegler, M. Muller, and P. P. Nawroth Advanced Glycation End Product (AGE)–Mediated Induction of Tissue Factor in Cultured Endothelial Cells Is Dependent on RAGE Circulation, October 7, 1997; 96(7): 2262 - 2271. [Abstract] [Full Text] |
||||
![]() |
H. M. Lander, J. M. Tauras, J. S. Ogiste, O. Hori, R. A. Moss, and A. M. Schmidt Activation of the Receptor for Advanced Glycation End Products Triggers a p21ras-dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress J. Biol. Chem., July 11, 1997; 272(28): 17810 - 17814. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Renard, O. Chappey, M.-P. Wautier, M. Nagashima, E. Lundh, J. Morser, L. Zhao, A.-M. Schmidt, J.-M. Scherrmann, and J.-L. Wautier Recombinant Advanced Glycation End Product Receptor Pharmacokinetics in Normal and Diabetic Rats Mol. Pharmacol., July 1, 1997; 52(1): 54 - 62. [Abstract] [Full Text] |
||||
![]() |
J. Li and A. M. Schmidt Characterization and Functional Analysis of the Promoter of RAGE, the Receptor for Advanced Glycation End Products J. Biol. Chem., June 27, 1997; 272(26): 16498 - 16506. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Du Yan, H. Zhu, J. Fu, S. F. Yan, A. Roher, W. W. Tourtellotte, T. Rajavashisth, X. Chen, G. C. Godman, D. Stern, et al. Amyloid-beta peptide-Receptor for Advanced Glycation Endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory pathway in Alzheimer disease PNAS, May 13, 1997; 94(10): 5296 - 5301. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Booth, R. G. Khalifah, P. Todd, and B. G. Hudson In Vitro Kinetic Studies of Formation of Antigenic Advanced Glycation End Products (AGEs). NOVEL INHIBITION OF POST-AMADORI GLYCATION PATHWAYS J. Biol. Chem., February 28, 1997; 272(9): 5430 - 5437. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-F. Yan, Y. S. Zou, M. Mendelsohn, Y. Gao, Y. Naka, S. Du Yan, D. Pinsky, and D. Stern Nuclear Factor Interleukin 6Motifs Mediate Tissue-specific Gene Transcription in Hypoxia J. Biol. Chem., February 14, 1997; 272(7): 4287 - 4294. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Hori, J. Brett, T. Slattery, R. Cao, J. Zhang, J. X. Chen, M. Nagashima, E. R. Lundh, S. Vijay, D. Nitecki, et al. The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin J. Biol. Chem., October 27, 1995; 270(43): 25752 - 25761. [Abstract] [Full Text] [PDF] |
||||